A Pilot Biomarker Study Assessing Alpha-synuclein Aggregates Across Biofluid Reservoirs in Patients With Synucleinopathies

Stopped The assay under investigation did not show evidence of accurately detecting alpha-synuclein in specimens collected in the study other than CSF and the intention of the study was to identify less invasive ways to measure alpha-synuclein.

Conditions

• Parkinson Disease
• Multiple System Atrophy
• Rapid Eye Movement Sleep Behavior Disorder
• Normal Pressure Hydrocephalus

Interventions

• OTHER: Biomarker assay

Sponsor

Stony Brook University